CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,827,509 | -15.6% | 15,383,020 | -3.0% | 0.01% | -16.7% |
| Q2 2023 | $213,049,031 | -16.3% | 15,851,862 | +3.2% | 0.01% | -25.0% |
| Q1 2023 | $254,673,945 | -12.7% | 15,360,310 | -2.1% | 0.01% | -11.1% |
| Q4 2022 | $291,840,069 | +49.0% | 15,690,326 | +2.8% | 0.01% | +28.6% |
| Q3 2022 | $195,902,000 | +302.0% | 15,268,931 | +119.6% | 0.01% | +250.0% |
| Q2 2022 | $48,732,000 | -21.0% | 6,951,816 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $61,696,000 | +18.6% | 7,442,609 | -3.2% | 0.00% | +100.0% |
| Q4 2021 | $52,024,000 | +23.3% | 7,684,698 | -3.5% | 0.00% | 0.0% |
| Q3 2021 | $42,201,000 | -8.3% | 7,962,533 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $46,033,000 | +20.7% | 8,005,837 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $38,147,000 | +47.5% | 8,274,686 | +6.9% | 0.00% | 0.0% |
| Q4 2020 | $25,866,000 | +16.6% | 7,744,197 | +3.7% | 0.00% | 0.0% |
| Q3 2020 | $22,184,000 | -37.1% | 7,469,297 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $35,280,000 | +8.2% | 7,636,353 | -9.8% | 0.00% | -50.0% |
| Q1 2020 | $32,593,000 | +2.9% | 8,465,550 | +0.2% | 0.00% | +100.0% |
| Q4 2019 | $31,668,000 | -27.8% | 8,444,965 | +2.3% | 0.00% | -50.0% |
| Q3 2019 | $43,833,000 | +41.3% | 8,255,022 | +2.2% | 0.00% | +100.0% |
| Q2 2019 | $31,023,000 | -13.0% | 8,078,995 | +15.6% | 0.00% | -50.0% |
| Q1 2019 | $35,643,000 | +166.3% | 6,988,724 | +0.3% | 0.00% | +100.0% |
| Q4 2018 | $13,384,000 | -43.4% | 6,970,873 | +11.5% | 0.00% | 0.0% |
| Q3 2018 | $23,633,000 | +25.0% | 6,251,780 | +3.2% | 0.00% | 0.0% |
| Q2 2018 | $18,905,000 | +68.3% | 6,059,627 | +29.0% | 0.00% | 0.0% |
| Q1 2018 | $11,230,000 | -28.5% | 4,698,531 | +16.9% | 0.00% | 0.0% |
| Q4 2017 | $15,717,000 | +67.6% | 4,019,581 | +8.0% | 0.00% | – |
| Q3 2017 | $9,379,000 | -5.3% | 3,721,537 | +3.7% | 0.00% | -100.0% |
| Q2 2017 | $9,901,000 | +819.3% | 3,587,286 | +548.9% | 0.00% | – |
| Q1 2017 | $1,077,000 | +35800.0% | 552,803 | +18072.4% | 0.00% | – |
| Q1 2016 | $3,000 | -40.0% | 3,042 | +61.9% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 1,879 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -25.0% | 1,879 | 0.0% | 0.00% | – |
| Q2 2015 | $8,000 | – | 1,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |